Advertisement
Screener

GSK plc (GLAXF) Form 6-K: Report of foreign private issuer, 2014, Page 3

GSK plc Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2014-03-03: Form 6-K; Period of report 2014-03-03; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201403036k2.htm.
  • 2014-03-03: Form 6-K; Period of report 2014-03-03; Description TOTAL VOTING RIGHTS; Document gsk201403036k1.htm.
  • 2014-03-03: Form 6-K; Period of report 2014-03-03; Description GSK FILES ITS ANNUAL REPORT 2013 ON FORM 20F; Document gsk201403036k.htm.
  • 2014-02-27: Form 6-K; Period of report 2014-02-27; Description ANNUAL FINANCIAL REPORT; Document gsk201402276k.htm.
FiledFormPeriod of reportDescriptionDocument
2014-03-036-K2014-03-03DIRECTOR/PDMR SHAREHOLDINGgsk201403036k2.htm
2014-03-036-K2014-03-03TOTAL VOTING RIGHTSgsk201403036k1.htm
2014-03-036-K2014-03-03GSK FILES ITS ANNUAL REPORT 2013 ON FORM 20Fgsk201403036k.htm
2014-02-276-K2014-02-27ANNUAL FINANCIAL REPORTgsk201402276k.htm
2014-02-276-K2014-02-27TRANSACTION IN OWN SHARESgsk201402276k2.htm
2014-02-266-K2014-02-26TRANSACTION IN OWN SHARESgsk201402266k3.htm
2014-02-266-K2014-02-26DIRECTOR/PDMR SHAREHOLDINGgsk201402266k2.htm
2014-02-266-K2014-02-26DIRECTOR/PDMR SHAREHOLDINGgsk201402266k1.htm
2014-02-266-K2014-02-26DIRECTOR/PDMR SHAREHOLDINGgsk201402266k.htm
2014-02-256-K2014-02-25TRANSACTION IN OWN SHARESgsk201402256k3.htm
2014-02-256-K2014-02-25DIRECTOR DECLARATIONgsk201402256k2.htm
2014-02-256-K2014-02-25DIRECTOR/PDMR SHAREHOLDINGgsk201402256k1.htm
2014-02-256-K2014-02-25DIRECTOR/PDMR SHAREHOLDINGgsk201402256k.htm
2014-02-216-K2014-02-21TRANSACTION IN OWN SHARESgsk201402216k2.htm
2014-02-216-K2014-02-21DIRECTOR/PDMR SHAREHOLDINGgsk201402216k.htm
2014-02-216-K2014-02-20INCRUSE RECEIVES POSITIVE CHMP OPINIONgsk201402206k2.htm
2014-02-216-K2014-02-20TRANSACTION IN OWN SHARESgsk201402206k1.htm
2014-02-206-K2014-02-20ANORO RECEIVES POSITIVE CHMP OPINIONgsk201402206k.htm
2014-02-186-K2014-02-17DIRECTOR/PDMR SHAREHOLDINGgsk201402176k5.htm
2014-02-186-K2014-02-17TRANSACTION IN OWN SHARESgsk201402176k4.htm
2014-02-186-K2014-02-17DIRECTOR/PDMR SHAREHOLDINGgsk201402176k.htm
2014-02-186-K2014-02-17DIRECTOR/PDMR SHAREHOLDINGgsk201402176k3.htm
2014-02-186-K2014-02-17DIRECTOR/PDMR SHAREHOLDINGgsk201402176k2.htm
2014-02-146-K2014-02-13DIRECTOR/PDMR SHAREHOLDINGgsk201402146k1.htm
2014-02-146-K2014-02-13DIRECTOR/PDMR SHAREHOLDINGgsk201402146k.htm
2014-02-136-K2014-02-13DIRECTOR/PDMR SHAREHOLDINGgsk201402136k2.htm
2014-02-136-K2014-02-13DIRECTOR/PDMR SHAREHOLDINGgsk201402136k1.htm
2014-02-136-K2014-02-13DIRECTOR/PDMR SHAREHOLDINGgsk201402136k.htm
2014-02-126-K2014-02-12TRANSACTION IN OWN SHARESgsk201402126k2.htm
2014-02-126-K2014-02-12DIRECTOR/PDMR SHAREHOLDINGgsk201402126k1.htm
2014-02-126-K2014-02-12DIRECTOR/PDMR SHAREHOLDINGgsk201402126k.htm
2014-02-116-K2014-02-11TRANSACTION IN OWN SHARESgsk201402116k1.htm
2014-02-116-K2014-02-11DIRECTOR/PDMR SHAREHOLDINGgsk201402116k.htm
2014-02-106-K2014-02-10DIRECTOR/PDMR SHAREHOLDINGgsk201402106k1.htm
2014-02-106-K2014-02-10DIRECTOR/PDMR SHAREHOLDINGgsk201402106k.htm
2014-02-076-K2014-02-07TRANSACTION IN OWN SHARESgsk201402076k.htm
2014-02-066-K2014-02-06TRANSACTION IN OWN SHARESgsk201402066k.htm
2014-02-056-K2014-02-05FINAL RESULTSgsk201402056k.htm
2014-02-046-K2014-02-04DIRECTOR DECLARATIONgsk201402046k.htm
2014-02-036-K2014-02-03DIRECTOR/PDMR SHAREHOLDINGgsk201402036k1.htm
2014-02-036-K2014-02-03TOTAL VOTING RIGHTSgsk201402036k.htm
2014-01-246-K2014-01-24MEK/BRAF COMBINATION PHASE III STUDY RESULTSgsk201401246k1.htm
2014-01-246-K2014-01-24EPERZAN (ALBIGLUTIDE) POSITIVE CHMP OPINIONgsk201401246k.htm
2014-01-216-K2014-01-21TIVICAY (DOLUTEGRAVIR) RECEIVES EUROPEAN APPROVALgsk201401216k.htm
2014-01-216-K2014-01-20DIRECTOR/PDMR SHAREHOLDINGgsk201401206k.htm
2014-01-176-K2014-01-17DIRECTOR/PDMR SHAREHOLDINGgsk201401176k.htm
2014-01-166-K2014-01-16DIRECTOR/PDMR SHAREHOLDINGgsk201401166k5.htm
2014-01-166-K2014-01-16DIRECTOR/PDMR SHAREHOLDINGgsk201401166k4.htm
2014-01-166-K2014-01-16DIRECTOR/PDMR SHAREHOLDINGgsk201401166k3.htm
2014-01-166-K2014-01-16DIRECTOR/PDMR SHAREHOLDINGgsk201401166k2.htm
2014-01-166-K2014-01-16DIRECTOR/PDMR SHAREHOLDINGgsk201401166k1.htm
2014-01-166-K2014-01-16DIRECTOR/PDMR SHAREHOLDINGgsk201401166k.htm
2014-01-156-K/A2014-01-15REPLACEMENT DIRECTOR/PDMR SHAREHOLDINGgsk201401156k-a.htm
2014-01-136-K2014-01-13DIRECTOR/PDMR SHAREHOLDINGgsk201401136k2.htm
2014-01-136-K2014-01-13DIRECTOR/PDMR SHAREHOLDINGgsk201401136k3.htm
2014-01-136-K2014-01-13DIRECTOR/PDMR SHAREHOLDINGgsk201401136k1.htm
2014-01-136-K2014-01-13DIRECTOR/PDMR SHAREHOLDINGgsk201401136k.htm
2014-01-106-K2014-01-10DIRECTOR/PDMR SHAREHOLDINGgsk201401106k2.htm
2014-01-106-K2014-01-10DIRECTOR/PDMR SHAREHOLDINGgsk201401106k.htm
2014-01-106-K2014-01-10DIRECTOR/PDMR SHAREHOLDINGgsk201401106k1.htm
2014-01-096-K2014-01-09DIRECTOR/PDMR SHAREHOLDINGgsk201401096k1.htm
2014-01-096-K2014-01-09FDA APPROVES MEK/BRAF COMBINATION THERAPYgsk201301096k.htm
2014-01-066-K2014-01-06DIRECTOR/PDMR SHAREHOLDINGgsk201401066k.htm
2014-01-036-K2014-01-03DIRECTOR/PDMR SHAREHOLDINGgsk201401036k1.htm
2014-01-036-K2014-01-03DIRECTOR/PDMR SHAREHOLDINGgsk201401036k.htm
2014-01-026-K2014-01-02TOTAL VOTING RIGHTSgsk201401026k.htm